I agree that this site is using cookies. You can find further informations here.
X
Tsurutani, Junji
174  results:
Search for persons X
?
1

Trastuzumab deruxtecan for human epidermal growth factor re..:

Hattori, Masaya ; Honma, Naoko ; Nagai, Shigenori...
Breast Cancer.  31 (2024)  3 - p. 335-339 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Trastuzumab deruxtecan versus treatment of physician's choi..:

Yamashita, Toshinari ; Sohn, Joo Hyuk ; Tokunaga, Eriko...
Breast Cancer.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Trastuzumab deruxtecan in patients with human epidermal gro..:

Takahashi, Shunji ; Bando, Hideaki ; Kinoshita, Ichiro...
Japanese Journal of Clinical Oncology.  54 (2024)  4 - p. 434-443 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Risk factors for recurrence in patients with hormone recept..:

Miyazaki, Naoki ; Iwasaki, Toshiki ; Sakai, Hitomi...
Current Medical Research and Opinion.  40 (2024)  5 - p. 827-837 , 2024
Link: https://doi.org/10.1080/..
 
?
5

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:

Bardia, Aditya ; Jhaveri, Komal ; Kalinsky, Kevin...
Future Oncology.  20 (2024)  8 - p. 423-436 , 2024
Link: https://doi.org/10.2217/..
 
?
6

Efficacy of probiotics and trimebutine maleate for abemacic..:

Masuda, Hiroko ; Tanabe, Yuko ; Sakai, Hitomi...
The Breast.  71 (2023)  - p. 22-28 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Trastuzumab deruxtecan versus trastuzumab emtansine in pati..:

Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang...
The Lancet.  401 (2023)  10371 - p. 105-117 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Efficacy, safety, and biomarker analysis of nivolumab in co..:

Masuda, Jun ; Sakai, Hitomi ; Tsurutani, Junji...
Journal for ImmunoTherapy of Cancer.  11 (2023)  9 - p. e007126 , 2023
Link: https://doi.org/10.1136/..
 
?
9

Analytical and clinical validation of PATHWAY Anti-HER-2/ne..:

Garrido, Charo ; Manoogian, Melissa ; Ghambire, Dhiraj...
Virchows Archiv.  484 (2023)  6 - p. 1005-1014 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Real-world treatment patterns and outcomes of abemaciclib f..:

Nozawa, K. ; Terada, M. ; Onishi, M....
Breast Cancer.  30 (2023)  4 - p. 657-665 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Treatment with trastuzumab deruxtecan in patients with HER2..:

Niikura, Naoki ; Yamanaka, Takashi ; Nomura, Hironori...
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

Multicentre, randomised, double-blind, placebo-controlled p..:

Sakai, Hitomi ; Tsurutani, Junji ; Ozaki, Yukinori...
BMJ Open.  13 (2023)  4 - p. e070304 , 2023
Link: https://doi.org/10.1136/..
 
?
13

Data of programmed death-ligand 1 expression and VEGF: Nivo..:

Ozaki, Yukinori ; Tsurutani, Junji ; Mukohara, Toru...
Data in Brief.  45 (2022)  - p. 108558 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Multidisciplinary clinical guidance on trastuzumab deruxtec..:

Swain, Sandra M. ; Nishino, Mizuki ; Lancaster, Lisa H....
Cancer Treatment Reviews.  106 (2022)  - p. 102378 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-..:

Matsuoka, Hiromichi ; Tsurutani, Junji ; Chiba, Yasutaka...
The Oncologist.  28 (2022)  3 - p. 278-e166 , 2022
Link: https://doi.org/10.1093/..
 
1-15